The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …

Despite intense research there is currently no effective vaccine available against the new
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the later 2019 …

At the time of writing this commentary (February 2020), the coronavirus COVID‐19 epidemic
has already resulted in more fatalities compared with the SARS and MERS coronavirus …

In December 2019, a novel severe acute respiratory syndrome (SARS) from a new
coronavirus (SARS-CoV-2) was recognized in the city of Wuhan, China. Rapidly, it became …

The ongoing outbreak of COVID-19 has quickly become a daunting challenge to global
health. In the absence of targeted therapy and a reported 5.5% case fatality rate in the …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes the corona virus
disease-19 which is accompanied by severe pneumonia, pulmonary alveolar collapses and …

The importance of host genetics and demography in coronavirus disease 2019 (COVID-19)
is a crucial aspect of infection, prognosis and associated case fatality rate. Individual genetic …

SARS-CoV-2 infection affects different organs and tissues, including the upper and lower
airways, the lung, the gut, the olfactory system and the eye, which may represent one of the …

The SARS-CoV-2 outbreak caused an unprecedented global public health threat, having a
high transmission rate with currently no drugs or vaccines approved. An alternative powerful …

Viruses are obligate intracellular parasites, and host cell entry is the first step in the viral life
cycle. The SARS‐CoV‐2 (COVID‐19) entry process into susceptible host tissue cells is …